SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-005969
Filing Date
2012-02-06
Accepted
2012-02-06 12:54:16
Documents
15
Period of Report
2012-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v301219_8k.htm 8-K 18852
2 EXHIBIT 10.1 v301219_ex10-1.htm EX-10.1 901
3 EXHIBIT 10.2 v301219_ex10-2.htm EX-10.2 901
4 EXHIBIT 99.1 v301219_ex99-1.htm EX-99.1 619
5 GRAPHIC ex10-1x1x1.jpg GRAPHIC 158796
6 GRAPHIC ex10-1x2x1.jpg GRAPHIC 145970
7 GRAPHIC ex10-1x3x1.jpg GRAPHIC 142341
8 GRAPHIC ex10-1x4x1.jpg GRAPHIC 76051
9 GRAPHIC ex10-2x1x1.jpg GRAPHIC 141064
10 GRAPHIC ex10-2x2x1.jpg GRAPHIC 162406
11 GRAPHIC ex10-2x3x1.jpg GRAPHIC 123266
12 GRAPHIC ex10-2x4x1.jpg GRAPHIC 55291
13 GRAPHIC v301219_ex99-1x1x1.jpg GRAPHIC 122773
14 GRAPHIC v301219_ex99-1x2x1.jpg GRAPHIC 153862
15 GRAPHIC v301219_ex99-1x3x1.jpg GRAPHIC 58424
  Complete submission text file 0001144204-12-005969.txt   1870691
Mailing Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021
Business Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021 516-482-1200
Neogenix Oncology Inc (Filer) CIK: 0001341293 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 8-K | Act: 34 | File No.: 000-53963 | Film No.: 12572818
SIC: 2835 In Vitro & In Vivo Diagnostic Substances